SODIUM CHLORIDE, HYDROCORTISONE UPJOHN 100 mg, préparation injectable, Placebo of hydrocortisone 100 mg, Reverpleg 40 U.I./2 ml solution à diluer pour perfusion
Phase 3 small_molecule active
Quick answer
SODIUM CHLORIDE, HYDROCORTISONE UPJOHN 100 mg, préparation injectable, Placebo of hydrocortisone 100 mg, Reverpleg 40 U.I./2 ml solution à diluer pour perfusion for Adult cardiac arrest patients with sustained ROSC and hemodynamic failure due to post-resuscitation syndrome is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Adult cardiac arrest patients with sustained ROSC and hemodynamic failure due to post-resuscitation syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active